WISE CV 325 Tablets
Composition: Cefpodoxime – 200 mg, Clavulanic Acid – 125 mg
Product Overview
WISE-CV 375 Tablets combine Cefpodoxime 200 mg + Clavulanic Acid 125 mg to provide enhanced antibacterial coverage against selected susceptible organisms, including bacteria producing certain β-lactamases.
Key Benefits
-
Combines a cephalosporin antibiotic with a β-lactamase inhibitor.
-
Provides broader antibacterial activity than cefpodoxime alone against selected susceptible organisms.
-
Clavulanic acid helps protect cefpodoxime from degradation by certain β-lactamase enzymes.
-
Useful in selected infections where β-lactamase-mediated resistance may be a consideration.
-
Provides convenient oral administration.
Common Therapeutic Applications
WISE-CV 375 may be prescribed for susceptible bacterial infections including:
-
Upper respiratory tract infections
-
Lower respiratory tract infections
-
Urinary tract infections
-
Skin and soft-tissue infections
-
Other infections where the combination is considered clinically appropriate
How It Works
-
Cefpodoxime acts by interfering with bacterial cell-wall synthesis, resulting in the death of susceptible bacteria.
-
Clavulanic acid acts as a β-lactamase inhibitor.
-
Certain bacteria produce β-lactamase enzymes that can inactivate β-lactam antibiotics.
-
Clavulanic acid inhibits susceptible β-lactamases, helping protect the antibiotic from enzymatic degradation.
-
The combination therefore provides complementary antibacterial activity against appropriate susceptible organisms.